S100B and metastatic malignant neoplasm in the lymph nodes: S100B expression has been negatively correlated with lymph node metastasis (Wang et al., 2021), inhibition of cell migration, better overall survival in luminal B breast cancer patients, and being a good distant metastases-free survival biomarker (Yen et al., 2018).